Dana-Farber Cancer Institute finds main GPT-4 concerns include falsehoods, high costs

The renowned medical institute trialed letting 12,500 staff members use a private instance of GPT-4, a first-of-its-kind implementation in medicine.

Related Keywords

Dana Farber Cancer Institute ,Massachusetts ,United States ,Boston ,Renato Umeton ,Azure Openai Service ,Dana Farber Generative Ai Governance Committee ,Dana Farber Cancer ,New England Journal ,Dana Farber Generative ,